2-propylvaleric acid
RxNorm 11118
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 11118 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: 2-propylvaleric acid.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
2-propylpentanoic acid
(Atom ID: 10794750)
SYPrescribable
Synonym (SY):
2-propylvaleric acid
(Atom ID: 10794751)
SYPrescribable
Synonym (SY):
Dipropylacetic acid
(Atom ID: 354974)
SYPrescribable
Synonym (SY):
DPA - dipropylacetic acid
(Atom ID: 5070958)
FNPrescribable
Full form of descriptor (FN):
Product containing valproic acid (medicinal product)
(Atom ID: 9263901)
PINPrescribable
Precise Ingredient (PIN):
Valproic acid
(Atom ID: 12256510)
PTPrescribable
Designated preferred name (PT):
Valproic acid
(Atom ID: 354950)
FNPrescribable
Full form of descriptor (FN):
Valproic acid (substance)
(Atom ID: 354980)
PTPrescribable
Designated preferred name (PT):
Valproic acid-containing product
(Atom ID: 10822516)
Patient Education
Valproic Acid
Valproic acid is used alone or with other medications to treat certain types of seizures. Valproic acid is also used to treat mania (episodes of frenzied, abnormally excited mood) in people with bipolar disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). It is also used to prevent migraine headaches but not to relieve headaches that have already begun. Valproic acid is in a class of medications called anticonvulsants. It works by increasing the amount of a certain natural substance in the brain.
[Learn More]
* Please review the disclaimer below.